Gsk (GSK) Current Assets (2009 - 2026)

Gsk (GSK) has 10 years of Current Assets data on file, last reported at $23.3 billion in Q4 2025.

• In Q4 2025, Current Assets rose 6.76% year-over-year to $23.3 billion; the TTM figure through Dec 2025 stood at $23.3 billion (up 6.76% YoY), while the FY2025 annual figure was $23.3 billion, up 6.76% from the prior year.
• Current Assets improved to $23.3 billion in Q4 2025, from $21.8 billion in the prior quarter.
• Across five years, Current Assets topped out at $25.2 billion in Q4 2021 and bottomed at $21.8 billion in Q4 2024.
• A 5-year average of $23.6 billion and a median of $23.3 billion in 2025 frame the typical range for Current Assets.
• Annual changes were most pronounced in 2021 — Current Assets fell 5.84% — and 2025, when it increased 6.76%.
• Year by year, Current Assets stood at $25.2 billion in 2021, then declined by 3.23% to $24.4 billion in 2022, then retreated by 5.01% to $23.1 billion in 2023, then fell by 5.72% to $21.8 billion in 2024, then grew by 6.76% to $23.3 billion in 2025.
• The last three Current Assets figures came in at $23.3 billion (Q4 2025), $21.8 billion (Q4 2024), and $23.1 billion (Q4 2023), per Business Quant data.

Peer Comparison